{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Lingling Xu, Esther Wollert",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Clearance systems in the brain-implications for Alzheimer disease.",
      "version": "1.0.1"
    },
    "namespace_pattern": {
      "TAXONOMY": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "INTERPRO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/interpro/interpro-20170731.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mesh-names.belns",
      "MGI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20170725.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "RGD": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20170725.belns"
    },
    "path": "tau/tarasoffconway2015.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Emerging evidence suggests that Aβ clearance is impaired in both early-onset and late-onset forms of AD.",
      "key": "3432f3d08f93a7f5ebfd7949ec210af4",
      "line": 68,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 77,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "When characterized by autosomal dominant inheritance, EOAD is related to mutations in the presenilin 1 (PSEN1), presenilin 2 (PSEN2) or amyloid precursor protein (APP) genes.",
      "key": "49f6a974a7abee5f9a22cbb5d46ffe74",
      "line": 110,
      "relation": "association",
      "source": 77,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "When characterized by autosomal dominant inheritance, EOAD is related to mutations in the presenilin 1 (PSEN1), presenilin 2 (PSEN2) or amyloid precursor protein (APP) genes.",
      "key": "388014241227e2d226765b63aca14d6c",
      "line": 111,
      "relation": "association",
      "source": 77,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "When characterized by autosomal dominant inheritance, EOAD is related to mutations in the presenilin 1 (PSEN1), presenilin 2 (PSEN2) or amyloid precursor protein (APP) genes.",
      "key": "06074a3b79316397ebe90eba733989f9",
      "line": 112,
      "relation": "association",
      "source": 77,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "The strongest identified genetic risk factor for LOAD is the apolipoprotein E (APOE) ε4 allele (APOE*ε4),",
      "key": "ec0c5953df2c36cd69a0936378be2f1b",
      "line": 123,
      "relation": "positiveCorrelation",
      "source": 77,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "although genome-wide association studies have linked LOAD to several other genetic variants, such as TREM2 (triggering receptor expressed on myeloid cells 2), 27 clusterin (CLU),28 and phosphatidylinositol-binding clathrin assembly protein (PICALM).",
      "key": "b1fe20cd424f959a91cf66ed5902fe01",
      "line": 130,
      "relation": "association",
      "source": 77,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "although genome-wide association studies have linked LOAD to several other genetic variants, such as TREM2 (triggering receptor expressed on myeloid cells 2), 27 clusterin (CLU),28 and phosphatidylinositol-binding clathrin assembly protein (PICALM).",
      "key": "01d3c6eaac47b22e200c783a11c2bd37",
      "line": 131,
      "relation": "association",
      "source": 77,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "although genome-wide association studies have linked LOAD to several other genetic variants, such as TREM2 (triggering receptor expressed on myeloid cells 2), 27 clusterin (CLU),28 and phosphatidylinositol-binding clathrin assembly protein (PICALM).",
      "key": "c15130e895640ee8e0334526cb47fa4d",
      "line": 132,
      "relation": "association",
      "source": 77,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Parietal Lobe": true,
          "Temporal Lobe": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "key": "c7073d2af68eabc990cd6b1a1559117a",
      "line": 154,
      "relation": "positiveCorrelation",
      "source": 77,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Recent advances now enable several AD-related brain changes to be detected in vivo: 18F-FDG-PET detects decreases in glucose metabolism,45,46 and MRI detects brain atrophy, as well as diffusion and perfu- sion abnormalities, which are most prominent in the vul- nerable hippocampal formation and cortical regions.",
      "key": "3a4150b0829d75d818ad1d74d8a73fe0",
      "line": 179,
      "relation": "decreases",
      "source": 77,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "key": "60e1e5d0696a836cdc41c6b3b2a712e1",
      "line": 156,
      "relation": "negativeCorrelation",
      "source": 77,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "key": "ba01fd405c44afcc9337e056b02a882e",
      "line": 157,
      "relation": "positiveCorrelation",
      "source": 77,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "key": "dad6e2c54796af85a130b1c9073aa020",
      "line": 158,
      "relation": "association",
      "source": 77,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Recent advances now enable several AD-related brain changes to be detected in vivo: 18F-FDG-PET detects decreases in glucose metabolism,45,46 and MRI detects brain atrophy, as well as diffusion and perfu- sion abnormalities, which are most prominent in the vul- nerable hippocampal formation and cortical regions.",
      "key": "8148bf02068de3a24432caaf4af9cb06",
      "line": 177,
      "relation": "decreases",
      "source": 77,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "First, expression of neprilysin is decreased in AD,126 especially in regions with high Aβ loads such as the hippocampus and temporal gyrus.127 ",
      "key": "ee0e6636e76da3e101bbd24e8c422e23",
      "line": 279,
      "relation": "negativeCorrelation",
      "source": 77,
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Although overall matrix metallo- proteinase 2 expression is increased in AD, 58 its activity is reduced in astrocytes that surround Aβ plaques.",
      "key": "70a12ed15c3944aac9769b09674d2e5f",
      "line": 285,
      "relation": "positiveCorrelation",
      "source": 77,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "In AD, these factors are impaired in a number of ways. First, expression of the blood efflux transporters LRP1 123 and ABCB1 147 is decreased, whereas expression of the blood influx transporter RAGE is upregulated.",
      "key": "3c697f47d63fee23ab3900ae4af8e1d7",
      "line": 375,
      "relation": "negativeCorrelation",
      "source": 77,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "In AD, these factors are impaired in a number of ways. First, expression of the blood efflux transporters LRP1 123 and ABCB1 147 is decreased, whereas expression of the blood influx transporter RAGE is upregulated.",
      "key": "695f44dc51c92a256788e893e7209816",
      "line": 376,
      "relation": "negativeCorrelation",
      "source": 77,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "In AD, these factors are impaired in a number of ways. First, expression of the blood efflux transporters LRP1 123 and ABCB1 147 is decreased, whereas expression of the blood influx transporter RAGE is upregulated.",
      "key": "d0abdc2ca1b1b930b1958fd1ad34fcd7",
      "line": 377,
      "relation": "positiveCorrelation",
      "source": 77,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " First, in ageing, and particularly in AD, CSF production by the choroid plexus is reduced, as shown by decreased water secretion into the ventricles via AQP1 water channels.",
      "key": "82be9b122d265213715fc41fdf22d0e7",
      "line": 476,
      "relation": "negativeCorrelation",
      "source": 77,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " First, in ageing, and particularly in AD, CSF production by the choroid plexus is reduced, as shown by decreased water secretion into the ventricles via AQP1 water channels.",
      "key": "9f884fadef1f26b705eff9a4fe9b550d",
      "line": 478,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 77,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Choroid Plexus": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "In AD, the choroid plexus undergoes many structural changes, such as calcification, fibrosis and Aβ deposition, all of which can obstruct CSF production.",
      "key": "eef0c257f01859b4a88c2bdd6b1ba79f",
      "line": 487,
      "relation": "increases",
      "source": 77,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Choroid Plexus": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "In AD, the choroid plexus undergoes many structural changes, such as calcification, fibrosis and Aβ deposition, all of which can obstruct CSF production.",
      "key": "f99125bcaf58d0adcfe990d2f926a6f9",
      "line": 488,
      "relation": "increases",
      "source": 77,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Choroid Plexus": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "In AD, the choroid plexus undergoes many structural changes, such as calcification, fibrosis and Aβ deposition, all of which can obstruct CSF production.",
      "key": "e0ddfc19e71757b598a6b4060555aac7",
      "line": 489,
      "relation": "increases",
      "source": 77,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "ApoE is a cholesterol transporter that competes with Aβ for efflux by LRP1 from the interstitium into the circula- tion;",
      "key": "38ec72d1b4370d0278140ccf62cad89f",
      "line": 393,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cardiovascular System",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "negativeCorrelation",
      "source": 2,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cardiovascular System",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "The pres- ence of ApoE4 is associated with reduced perivascular drainage of Aβ,161 which in turn is linked to deposition of immune complexes.",
      "key": "a70abbd1b693955813882b04431b6f63",
      "line": 432,
      "relation": "positiveCorrelation",
      "source": 2,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Soluble Aβ can be removed from the brain by various clearance systems, including enzymatic degradation and cellular uptake, transport across the blood–brain barrier (BBB) and blood–cerebrospinal fluid barrier (BCSFB), interstitial fluid (ISF) bulk flow, and cerebro- spinal fluid (CSF) absorption into the circulatory and lymphatic systems.",
      "key": "249ae1fe47af30c900b9608950bf09fa",
      "line": 78,
      "relation": "decreases",
      "source": 5,
      "subject": {
        "modifier": "Degradation"
      },
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Soluble Aβ can be removed from the brain by various clearance systems, including enzymatic degradation and cellular uptake, transport across the blood–brain barrier (BBB) and blood–cerebrospinal fluid barrier (BCSFB), interstitial fluid (ISF) bulk flow, and cerebro- spinal fluid (CSF) absorption into the circulatory and lymphatic systems.",
      "key": "d426c259a21964f148f4404d1b801632",
      "line": 79,
      "relation": "decreases",
      "source": 5,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "extracellular region",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "Intracellular Space",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Soluble Aβ can be removed from the brain by various clearance systems, including enzymatic degradation and cellular uptake, transport across the blood–brain barrier (BBB) and blood–cerebrospinal fluid barrier (BCSFB), interstitial fluid (ISF) bulk flow, and cerebro- spinal fluid (CSF) absorption into the circulatory and lymphatic systems.",
      "key": "11b4d19f7f2e875e8b90286027d83366",
      "line": 80,
      "relation": "decreases",
      "source": 5,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "Brain",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Blood",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Soluble Aβ can be removed from the brain by various clearance systems, including enzymatic degradation and cellular uptake, transport across the blood–brain barrier (BBB) and blood–cerebrospinal fluid barrier (BCSFB), interstitial fluid (ISF) bulk flow, and cerebro- spinal fluid (CSF) absorption into the circulatory and lymphatic systems.",
      "key": "81544cbd65ef115a0b09c777fae22a8a",
      "line": 81,
      "relation": "decreases",
      "source": 5,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "Blood",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cerebrospinal Fluid",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Soluble Aβ can be removed from the brain by various clearance systems, including enzymatic degradation and cellular uptake, transport across the blood–brain barrier (BBB) and blood–cerebrospinal fluid barrier (BCSFB), interstitial fluid (ISF) bulk flow, and cerebro- spinal fluid (CSF) absorption into the circulatory and lymphatic systems.",
      "key": "cb511763c9acbdaf7cbc7060a0496cdc",
      "line": 82,
      "relation": "decreases",
      "source": 5,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "Brain",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Extracellular Fluid",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Soluble Aβ can be removed from the brain by various clearance systems, including enzymatic degradation and cellular uptake, transport across the blood–brain barrier (BBB) and blood–cerebrospinal fluid barrier (BCSFB), interstitial fluid (ISF) bulk flow, and cerebro- spinal fluid (CSF) absorption into the circulatory and lymphatic systems.",
      "key": "be11fc6d0799245eda88171a0c29a580",
      "line": 83,
      "relation": "decreases",
      "source": 5,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "Cerebrospinal Fluid",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cardiovascular System",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Soluble Aβ can be removed from the brain by various clearance systems, including enzymatic degradation and cellular uptake, transport across the blood–brain barrier (BBB) and blood–cerebrospinal fluid barrier (BCSFB), interstitial fluid (ISF) bulk flow, and cerebro- spinal fluid (CSF) absorption into the circulatory and lymphatic systems.",
      "key": "3ad99c28bab0231703d2ac73968b748a",
      "line": 84,
      "relation": "decreases",
      "source": 5,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "Cerebrospinal Fluid",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Lymphatic System",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "In the early 2000s, mouse studies demonstrated that the majority (75%) of extracellular Aβ (eAβ) is cleared by the BBB, with only a minority (10%) being cleared by ISF bulk flow.",
      "key": "dbecc29d2c6eb7768308e9c72fe212ed",
      "line": 93,
      "object": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        }
      },
      "relation": "decreases",
      "source": 6,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "When characterized by autosomal dominant inheritance, EOAD is related to mutations in the presenilin 1 (PSEN1), presenilin 2 (PSEN2) or amyloid precursor protein (APP) genes.",
      "key": "8beb38393c00bb66f737dfdd4224ff59",
      "line": 110,
      "relation": "association",
      "source": 31,
      "target": 77
    },
    {
      "key": "8366b5fccdf2874d4f6b0c95b0cd1a88",
      "relation": "hasVariant",
      "source": 30,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "When characterized by autosomal dominant inheritance, EOAD is related to mutations in the presenilin 1 (PSEN1), presenilin 2 (PSEN2) or amyloid precursor protein (APP) genes.",
      "key": "84acdf3b603e83230728cdefe8d98551",
      "line": 111,
      "relation": "association",
      "source": 33,
      "target": 77
    },
    {
      "key": "32d348762538e6043fab44f8bad602e4",
      "relation": "hasVariant",
      "source": 32,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "When characterized by autosomal dominant inheritance, EOAD is related to mutations in the presenilin 1 (PSEN1), presenilin 2 (PSEN2) or amyloid precursor protein (APP) genes.",
      "key": "25b95e1dcbb1dcf9b1d2e4febe23ffdb",
      "line": 112,
      "relation": "association",
      "source": 29,
      "target": 77
    },
    {
      "key": "c26ac6b2e0088f81fabe5b43c4fa266b",
      "relation": "hasVariant",
      "source": 28,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Various factors have been reported to positively and negatively modulate the risk of LOAD. Specifically, the greatest overall risk factor for LOAD is ageing;",
      "key": "d1719ee69f8a0477b97ffe07142b7649",
      "line": 118,
      "relation": "increases",
      "source": 87,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " First, in ageing, and particularly in AD, CSF production by the choroid plexus is reduced, as shown by decreased water secretion into the ventricles via AQP1 water channels.",
      "key": "29341897f46e343c5e6c03f3dbb1f088",
      "line": 475,
      "relation": "negativeCorrelation",
      "source": 87,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " First, in ageing, and particularly in AD, CSF production by the choroid plexus is reduced, as shown by decreased water secretion into the ventricles via AQP1 water channels.",
      "key": "1d9f4ad5fc9df5f768b75cb21904be0f",
      "line": 477,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 87,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "The strongest identified genetic risk factor for LOAD is the apolipoprotein E (APOE) ε4 allele (APOE*ε4),",
      "key": "ff8daa3cf269372843cce7ad43d634ba",
      "line": 123,
      "relation": "positiveCorrelation",
      "source": 27,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Third, ApoE4 is also associated with lower antioxidant activity than other ApoE isoforms,154,155 and it mediates BBB breakdown through a proinflammatory pathway involving cyclophilin A in pericytes.",
      "key": "8f12e8ff54a4e66c246d6324293c0ec0",
      "line": 406,
      "relation": "regulates",
      "source": 27,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Third, ApoE4 is also associated with lower antioxidant activity than other ApoE isoforms,154,155 and it mediates BBB breakdown through a proinflammatory pathway involving cyclophilin A in pericytes.",
      "key": "0e6bcfb872210933aedde6443aa2dfb7",
      "line": 407,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 27,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "The pres- ence of ApoE4 is associated with reduced perivascular drainage of Aβ,161 which in turn is linked to deposition of immune complexes.",
      "key": "29ad514ae53988fe5bc47fbb24a08555",
      "line": 432,
      "relation": "positiveCorrelation",
      "source": 27,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "although genome-wide association studies have linked LOAD to several other genetic variants, such as TREM2 (triggering receptor expressed on myeloid cells 2), 27 clusterin (CLU),28 and phosphatidylinositol-binding clathrin assembly protein (PICALM).",
      "key": "77519dd285340a199bfb737970d15e36",
      "line": 130,
      "relation": "association",
      "source": 69,
      "target": 77
    },
    {
      "key": "4e478ebae3af6e220e51b43918a03bb4",
      "relation": "hasVariant",
      "source": 68,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "although genome-wide association studies have linked LOAD to several other genetic variants, such as TREM2 (triggering receptor expressed on myeloid cells 2), 27 clusterin (CLU),28 and phosphatidylinositol-binding clathrin assembly protein (PICALM).",
      "key": "e38d5908d3499c7deb06421c4b934c6d",
      "line": 131,
      "relation": "association",
      "source": 48,
      "target": 77
    },
    {
      "key": "4365d4b4886adeb40f929b97c0c5962f",
      "relation": "hasVariant",
      "source": 47,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "although genome-wide association studies have linked LOAD to several other genetic variants, such as TREM2 (triggering receptor expressed on myeloid cells 2), 27 clusterin (CLU),28 and phosphatidylinositol-binding clathrin assembly protein (PICALM).",
      "key": "b80bd167bd514dfb74694d0141a64824",
      "line": 132,
      "relation": "association",
      "source": 64,
      "target": 77
    },
    {
      "key": "2e2bf476aa511b532fe98702009eca7d",
      "relation": "hasVariant",
      "source": 63,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "key": "ac4545e9f02084c9ce8600acd3ff436e",
      "line": 140,
      "relation": "increases",
      "source": 80,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "key": "0a539acd4209fbe4d0730d4645aa467b",
      "line": 141,
      "relation": "increases",
      "source": 83,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "key": "cdd19967854050d695760bb193414643",
      "line": 142,
      "relation": "increases",
      "source": 90,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "key": "35d6faba7cf8644c2ff2f9378ec45713",
      "line": 143,
      "relation": "increases",
      "source": 82,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "key": "2f1b6e000fd912044257d54fd2f3c03d",
      "line": 144,
      "relation": "decreases",
      "source": 25,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "key": "b1252f2c762f8ba1f2efcde2e0173ec6",
      "line": 145,
      "relation": "decreases",
      "source": 93,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Known envi- ronmental risk factors for LOAD include cardiovascular disease, and factors conferring a risk of cardiovascu- lar disease, such as diabetes mellitus and hypertension. Head trauma, physical and mental inactivity, and sleep impairment are additional risk factors for LOAD",
      "key": "5c45a63a0738d53dada3608d72bb7c2f",
      "line": 146,
      "relation": "increases",
      "source": 86,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "These findings might partly explain why sleep impairment increases the risk of AD",
      "key": "85f4c3ccb726a207363971a342339bf2",
      "line": 469,
      "relation": "increases",
      "source": 86,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Parietal Lobe": true,
          "Temporal Lobe": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "key": "aba04c7ae0332a2f075982e53f63662b",
      "line": 154,
      "relation": "positiveCorrelation",
      "source": 88,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "key": "19c62999b50e50ac3f9223b061f46e62",
      "line": 156,
      "relation": "negativeCorrelation",
      "source": 7,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "key": "6ed661511cd6b3e1a9f595d3adec2f11",
      "line": 157,
      "relation": "positiveCorrelation",
      "source": 8,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " The gross pathological changes consist of brain atrophy, particularly in the hippocampal formation, temporal lobes and parietotemporal cortices, accompanied by cortical thinning, enlarged ventricles and white matter abnormalities, as evident on MRI.",
      "key": "da803343f0c764cadf00ccdb66c60570",
      "line": 158,
      "relation": "association",
      "source": 13,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Microscopic changes include accumulation of Aβ into parenchymal senile plaques (also known as neuritic plaques) or in the walls of cerebral capillaries and #arter- ies (known as cerebral amyloid angiopathy, or CAA),as well as aggregation of hyperphosphorylated tau int o intracellular neurofibrillary tangles (NFTs) and neuropil #threads",
      "key": "f6eb0cfb537a3e4b814cac13e8d015df",
      "line": 166,
      "relation": "association",
      "source": 4,
      "target": 85
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Microscopic changes include accumulation of Aβ into parenchymal senile plaques (also known as neuritic plaques) or in the walls of cerebral capillaries and #arter- ies (known as cerebral amyloid angiopathy, or CAA),as well as aggregation of hyperphosphorylated tau int o intracellular neurofibrillary tangles (NFTs) and neuropil #threads",
      "key": "ef07aab885de9a46f7155b3af110f6de",
      "line": 167,
      "relation": "association",
      "source": 4,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "ecifically, Aβ accumulation into extracellular plaques is marked by decreased CSF levels of Aβ1–42, and tau accumulation into NFTs is marked by increased CSF levels of total tau and hyperphosphory- lated tau.",
      "key": "899c36b58460310819d29049edb51729",
      "line": 187,
      "object": {
        "location": {
          "name": "Cerebrospinal Fluid",
          "namespace": "MESH"
        }
      },
      "relation": "negativeCorrelation",
      "source": 4,
      "subject": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        }
      },
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Choroid Plexus": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "In AD, the choroid plexus undergoes many structural changes, such as calcification, fibrosis and Aβ deposition, all of which can obstruct CSF production.",
      "key": "6cbf373a7f44285436c7d2e60372c4db",
      "line": 492,
      "relation": "decreases",
      "source": 4,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Microscopic changes include accumulation of Aβ into parenchymal senile plaques (also known as neuritic plaques) or in the walls of cerebral capillaries and #arter- ies (known as cerebral amyloid angiopathy, or CAA),as well as aggregation of hyperphosphorylated tau int o intracellular neurofibrillary tangles (NFTs) and neuropil #threads",
      "key": "38ff8403cc9c4b60f6917dea6c90ee41",
      "line": 166,
      "relation": "association",
      "source": 85,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Astrocytes": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Although overall matrix metallo- proteinase 2 expression is increased in AD, 58 its activity is reduced in astrocytes that surround Aβ plaques.",
      "key": "2037d4988b0ef58ee6b3dcda208ba131",
      "line": 287,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 85,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Third, plaques activate the immune effectors of the CNS—microglia and astrocytes129—inducing both phagocytosis of Aβ, which facilitates clearance from the extracellular space, and production of neurotoxic inflammatory cytokines.",
      "key": "4b289823b14b3d627114c16e97ad011e",
      "line": 304,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 85,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Microscopic changes include accumulation of Aβ into parenchymal senile plaques (also known as neuritic plaques) or in the walls of cerebral capillaries and #arter- ies (known as cerebral amyloid angiopathy, or CAA),as well as aggregation of hyperphosphorylated tau int o intracellular neurofibrillary tangles (NFTs) and neuropil #threads",
      "key": "c883a9efca246889ba0470735ffd7f25",
      "line": 167,
      "relation": "association",
      "source": 81,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Microscopic changes include accumulation of Aβ into parenchymal senile plaques (also known as neuritic plaques) or in the walls of cerebral capillaries and #arter- ies (known as cerebral amyloid angiopathy, or CAA),as well as aggregation of hyperphosphorylated tau int o intracellular neurofibrillary tangles (NFTs) and neuropil #threads",
      "key": "0240223ea85c0b809eff8ea4fb0ed4dc",
      "line": 168,
      "relation": "association",
      "source": 57,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Microscopic changes include accumulation of Aβ into parenchymal senile plaques (also known as neuritic plaques) or in the walls of cerebral capillaries and #arter- ies (known as cerebral amyloid angiopathy, or CAA),as well as aggregation of hyperphosphorylated tau int o intracellular neurofibrillary tangles (NFTs) and neuropil #threads",
      "key": "50df384ffd9b7601440914360112ac69",
      "line": 169,
      "relation": "association",
      "source": 57,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "ecifically, Aβ accumulation into extracellular plaques is marked by decreased CSF levels of Aβ1–42, and tau accumulation into NFTs is marked by increased CSF levels of total tau and hyperphosphory- lated tau.",
      "key": "f0e1440e7b8cea8b352dc91cd7299080",
      "line": 189,
      "object": {
        "location": {
          "name": "Neurofibrillary Tangles",
          "namespace": "MESH"
        }
      },
      "relation": "positiveCorrelation",
      "source": 57,
      "subject": {
        "location": {
          "name": "Cerebrospinal Fluid",
          "namespace": "MESH"
        }
      },
      "target": 56
    },
    {
      "key": "b5ef526ab5a17da51fd96bb875e02aac",
      "relation": "hasVariant",
      "source": 56,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "ecifically, Aβ accumulation into extracellular plaques is marked by decreased CSF levels of Aβ1–42, and tau accumulation into NFTs is marked by increased CSF levels of total tau and hyperphosphory- lated tau.",
      "key": "7f0d549215e91bc7b0403754515651f0",
      "line": 189,
      "object": {
        "location": {
          "name": "Cerebrospinal Fluid",
          "namespace": "MESH"
        }
      },
      "relation": "positiveCorrelation",
      "source": 56,
      "subject": {
        "location": {
          "name": "Neurofibrillary Tangles",
          "namespace": "MESH"
        }
      },
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "ecifically, Aβ accumulation into extracellular plaques is marked by decreased CSF levels of Aβ1–42, and tau accumulation into NFTs is marked by increased CSF levels of total tau and hyperphosphory- lated tau.",
      "key": "a2788cdfebf4f8a499dc9f962303f01f",
      "line": 188,
      "object": {
        "location": {
          "name": "Neurofibrillary Tangles",
          "namespace": "MESH"
        }
      },
      "relation": "positiveCorrelation",
      "source": 56,
      "subject": {
        "location": {
          "name": "Cerebrospinal Fluid",
          "namespace": "MESH"
        }
      },
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "ecifically, Aβ accumulation into extracellular plaques is marked by decreased CSF levels of Aβ1–42, and tau accumulation into NFTs is marked by increased CSF levels of total tau and hyperphosphory- lated tau.",
      "key": "020fcd1900f589a00bf5f9dbd6d2a619",
      "line": 188,
      "object": {
        "location": {
          "name": "Cerebrospinal Fluid",
          "namespace": "MESH"
        }
      },
      "relation": "positiveCorrelation",
      "source": 56,
      "subject": {
        "location": {
          "name": "Neurofibrillary Tangles",
          "namespace": "MESH"
        }
      },
      "target": 56
    },
    {
      "key": "064f60bbd4e86ec0d71e89e733af2e71",
      "relation": "hasVariant",
      "source": 56,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Microscopic changes include accumulation of Aβ into parenchymal senile plaques (also known as neuritic plaques) or in the walls of cerebral capillaries and #arter- ies (known as cerebral amyloid angiopathy, or CAA),as well as aggregation of hyperphosphorylated tau int o intracellular neurofibrillary tangles (NFTs) and neuropil #threads",
      "key": "b48b4d9bd7ff0f5b77fece32b05c511d",
      "line": 168,
      "relation": "association",
      "source": 11,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Microscopic changes include accumulation of Aβ into parenchymal senile plaques (also known as neuritic plaques) or in the walls of cerebral capillaries and #arter- ies (known as cerebral amyloid angiopathy, or CAA),as well as aggregation of hyperphosphorylated tau int o intracellular neurofibrillary tangles (NFTs) and neuropil #threads",
      "key": "5cb4f74f40b4cb8375d9f074eb3dccfe",
      "line": 169,
      "relation": "association",
      "source": 12,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "ecifically, Aβ accumulation into extracellular plaques is marked by decreased CSF levels of Aβ1–42, and tau accumulation into NFTs is marked by increased CSF levels of total tau and hyperphosphory- lated tau.",
      "key": "81f17f5e1d6b7353f7765807a1677494",
      "line": 187,
      "object": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        }
      },
      "relation": "negativeCorrelation",
      "source": 1,
      "subject": {
        "location": {
          "name": "Cerebrospinal Fluid",
          "namespace": "MESH"
        }
      },
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "The most common soluble monomeric isoforms of Aβ are Aβ1-40 (<80%), Aβ1-38 (<20%) and Aβ1-42 (10%).",
      "key": "874a8b2f1bb9c28dda52755d0e541229",
      "line": 229,
      "relation": "isA",
      "source": 1,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Extracellular Fluid": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Extracellular degradation of ISF proteins mainly consists of degradation by proteases expressed and secreted by cells such as astrocytes",
      "key": "41dbbebcc14e6b672e6e2f154d19f1dd",
      "line": 196,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 14,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Specifically, ISF Aβ can be taken up by microglia and astrocytes, whereas perivascular Aβ can be degraded by vascular smooth muscle cells, perivascular macrophages, and astrocytes",
      "key": "3aa66e58116ba00e76e50b4f3db57fb9",
      "line": 269,
      "object": {
        "location": {
          "name": "Extracellular Fluid",
          "namespace": "MESH"
        }
      },
      "relation": "decreases",
      "source": 14,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Specifically, ISF Aβ can be taken up by microglia and astrocytes, whereas perivascular Aβ can be degraded by vascular smooth muscle cells, perivascular macrophages, and astrocytes",
      "key": "3e64c617e3c1614c39d9165247d97e60",
      "line": 272,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 14,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Extracellular Space": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Third, plaques activate the immune effectors of the CNS—microglia and astrocytes129—inducing both phagocytosis of Aβ, which facilitates clearance from the extracellular space, and production of neurotoxic inflammatory cytokines.",
      "key": "73efd266a4d68a0b4f6308ec13b5f521",
      "line": 307,
      "relation": "decreases",
      "source": 14,
      "subject": {
        "modifier": "Activity"
      },
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Extracellular Space": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Third, plaques activate the immune effectors of the CNS—microglia and astrocytes129—inducing both phagocytosis of Aβ, which facilitates clearance from the extracellular space, and production of neurotoxic inflammatory cytokines.",
      "key": "347029f7e6f1b6cba9f2e91108d38be6",
      "line": 309,
      "relation": "increases",
      "source": 14,
      "subject": {
        "modifier": "Activity"
      },
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Extracellular Fluid": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Extracellular degradation of ISF proteins mainly consists of degradation by proteases expressed and secreted by cells such as astrocytes",
      "key": "e23bf5fb6c513e4cc3888d7b4f1851c3",
      "line": 197,
      "relation": "increases",
      "source": 74,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Intracellular Aβ (iAβ) can be degraded by proteasomes via the ubiquitin–proteasome pathway in neurons,116 lyso- somal cathepsin enzymes,117 proteases (such as insulin- degrading enzyme, a thiol metalloendopeptidase that degrades monomeric Aβ) and insulin.",
      "key": "c71bb4b6a692062f09606c3cf80371f9",
      "line": 243,
      "object": {
        "location": {
          "name": "intracellular",
          "namespace": "GO"
        },
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 74,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Intracellular degradation of proteins occurs via the ubiquitin– proteasome pathway, the autophagy–lysosome pathway, and the endosome–lysosome pathway.",
      "key": "52d183f2905a71b30ba5e3339b8baf84",
      "line": 205,
      "relation": "increases",
      "source": 38,
      "subject": {
        "modifier": "Activity"
      },
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Intracellular Aβ (iAβ) can be degraded by proteasomes via the ubiquitin–proteasome pathway in neurons,116 lyso- somal cathepsin enzymes,117 proteases (such as insulin- degrading enzyme, a thiol metalloendopeptidase that degrades monomeric Aβ) and insulin.",
      "key": "75cd65cb330680b9167b9356fea51af4",
      "line": 238,
      "object": {
        "location": {
          "name": "intracellular",
          "namespace": "GO"
        },
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 38,
      "subject": {
        "modifier": "Activity"
      },
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Tau is mainly cleared through intracellular degrada- tion by lysosomes via the autophagy–lysosome pathway, and by proteasomes via the ubiquitin–proteasome pathway.202 ",
      "key": "575e77aaaa174b73dd1db7a50ecb72eb",
      "line": 502,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 38,
      "subject": {
        "modifier": "Activity"
      },
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Intracellular degradation of proteins occurs via the ubiquitin– proteasome pathway, the autophagy–lysosome pathway, and the endosome–lysosome pathway.",
      "key": "cfa9dc6f0cb604279ac476310624d583",
      "line": 206,
      "relation": "increases",
      "source": 23,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Intracellular degradation of proteins occurs via the ubiquitin– proteasome pathway, the autophagy–lysosome pathway, and the endosome–lysosome pathway.",
      "key": "4f506b431be399cb7311c603a997a42d",
      "line": 207,
      "relation": "increases",
      "source": 26,
      "subject": {
        "modifier": "Activity"
      },
      "target": 22
    },
    {
      "key": "fcdc6d38dd39887154fceb53d7c37518",
      "relation": "partOf",
      "source": 16,
      "target": 26
    },
    {
      "key": "a5205304f6f8d31433e047a647d16106",
      "relation": "partOf",
      "source": 17,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "APP is cleaved by α-secretase, which precludes forma- tion of Aβ, and the resulting carboxy-terminal fragment is then cleaved by γ-secretase.103 The resulting products do not aggregate.104",
      "key": "1a3223e57fa3140adcae0a507e6a42f6",
      "line": 215,
      "relation": "increases",
      "source": 71,
      "subject": {
        "modifier": "Activity"
      },
      "target": 94
    },
    {
      "key": "41ae55a87fc5e467d88c140db4fe2158",
      "relation": "hasReactant",
      "source": 94,
      "target": 44
    },
    {
      "key": "c1f7bc7440899943e5db35ee0e294d08",
      "relation": "hasProduct",
      "source": 94,
      "target": 2
    },
    {
      "key": "a53d943679ff34dc06113603542fd0ec",
      "relation": "hasProduct",
      "source": 94,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "APP is cleaved by α-secretase, which precludes forma- tion of Aβ, and the resulting carboxy-terminal fragment is then cleaved by γ-secretase.103 The resulting products do not aggregate.104",
      "key": "1fbbcd3aa49785e5fed0e2226581ca3b",
      "line": 216,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 36,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "If APP is first cleaved by β-secretase 1 (also known as BACE1) instead of α-secretase, the subsequent γ-secretase cleavage will result in soluble monomeric Aβ.",
      "key": "9dbe9c3f4f4ded1c7f381569aa11d8fc",
      "line": 222,
      "relation": "increases",
      "source": 46,
      "subject": {
        "modifier": "Activity"
      },
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "The most common soluble monomeric isoforms of Aβ are Aβ1-40 (<80%), Aβ1-38 (<20%) and Aβ1-42 (10%).",
      "key": "63ffe121711b5dda4e21e9c16f5911e1",
      "line": 228,
      "relation": "isA",
      "source": 0,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Lysosomes": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Intracellular Aβ (iAβ) can be degraded by proteasomes via the ubiquitin–proteasome pathway in neurons,116 lyso- somal cathepsin enzymes,117 proteases (such as insulin- degrading enzyme, a thiol metalloendopeptidase that degrades monomeric Aβ) and insulin.",
      "key": "42b889dbf19aa78da8f1158d31b2ca0f",
      "line": 241,
      "object": {
        "location": {
          "name": "intracellular",
          "namespace": "GO"
        },
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 73,
      "subject": {
        "modifier": "Activity"
      },
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Intracellular Aβ (iAβ) can be degraded by proteasomes via the ubiquitin–proteasome pathway in neurons,116 lyso- somal cathepsin enzymes,117 proteases (such as insulin- degrading enzyme, a thiol metalloendopeptidase that degrades monomeric Aβ) and insulin.",
      "key": "847828f91f80652cf3b6311451bb6d4d",
      "line": 244,
      "object": {
        "location": {
          "name": "intracellular",
          "namespace": "GO"
        },
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 52,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Extracellular Aβ can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the Aβ monomers Aβ1-40 and Aβ1-42, and Aβ oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "key": "8e12cc63e4e5892a7ba5b9ae9bba07a7",
      "line": 262,
      "object": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        },
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 52,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Second, both Aβ and insulin are ligands that compete for degradation by insulin-degrading enzyme; thus, hyper- insulinaemia can reduce clearance of Aβ, which might partly explain the link between type 2 diabetes mellitus and AD.",
      "key": "5acea3246baed09cfc6c047c40fb3277",
      "line": 296,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 52,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Blood-Brain Barrier": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "In addition, insulin-degrading enzyme has been proposed to have a role in Aβ clearance through the BBB, which might explain why BBB clearance is sensitive to insulin.144",
      "key": "88e8aa43e86bf346e8f478d723cfb0e3",
      "line": 347,
      "relation": "decreases",
      "source": 52,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Second, both Aβ and insulin are ligands that compete for degradation by insulin-degrading enzyme; thus, hyper- insulinaemia can reduce clearance of Aβ, which might partly explain the link between type 2 diabetes mellitus and AD.",
      "key": "72e2a3c49b108b2d8ecb87018dcaa7d6",
      "line": 295,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 52,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Extracellular Aβ can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the Aβ monomers Aβ1-40 and Aβ1-42, and Aβ oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "key": "3454e2bb7d97919bdfad5c8aab59a807",
      "line": 252,
      "object": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        },
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 59,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Extracellular Aβ can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the Aβ monomers Aβ1-40 and Aβ1-42, and Aβ oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "key": "c110e68483f52ebd479b26cf01974888",
      "line": 253,
      "object": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        },
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 62,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Extracellular Aβ can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the Aβ monomers Aβ1-40 and Aβ1-42, and Aβ oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "key": "bea097c0dc6cd6e00be5205621e3b5a1",
      "line": 254,
      "object": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        },
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 60,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Although overall matrix metallo- proteinase 2 expression is increased in AD, 58 its activity is reduced in astrocytes that surround Aβ plaques.",
      "key": "32ac0003f5c198a2be831e82dd4f41dd",
      "line": 285,
      "relation": "positiveCorrelation",
      "source": 60,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Astrocytes": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Although overall matrix metallo- proteinase 2 expression is increased in AD, 58 its activity is reduced in astrocytes that surround Aβ plaques.",
      "key": "06a6240abe7774a08c6174808a5d1ae5",
      "line": 287,
      "relation": "negativeCorrelation",
      "source": 60,
      "subject": {
        "modifier": "Activity"
      },
      "target": 85
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Extracellular Aβ can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the Aβ monomers Aβ1-40 and Aβ1-42, and Aβ oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "key": "7565e0e293ccd6897505689e0cbd5acc",
      "line": 255,
      "object": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        },
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 61,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Extracellular Aβ can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the Aβ monomers Aβ1-40 and Aβ1-42, and Aβ oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "key": "b9b2b31a9931caa59d4ef5524ba74a44",
      "line": 256,
      "object": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        },
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 51,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Extracellular Aβ can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the Aβ monomers Aβ1-40 and Aβ1-42, and Aβ oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "key": "99abc96ca959df29fab09964663ef70e",
      "line": 257,
      "object": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        },
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 49,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Extracellular Aβ can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the Aβ monomers Aβ1-40 and Aβ1-42, and Aβ oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "key": "2c818171786bedc0f3cf1c4af033c409",
      "line": 258,
      "object": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        },
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 50,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Extracellular Aβ can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the Aβ monomers Aβ1-40 and Aβ1-42, and Aβ oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "key": "a4b56399fc9da700566ad1347189b463",
      "line": 259,
      "object": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        },
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 65,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Extracellular Aβ can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the Aβ monomers Aβ1-40 and Aβ1-42, and Aβ oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "key": "df2fcd2208a0374236bccf31184d9a5a",
      "line": 260,
      "object": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        },
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 66,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Extracellular Aβ can also be degraded by proteases, such as neprily- sin (a membrane-anchored zinc metalloendopeptidase that degrades the Aβ monomers Aβ1-40 and Aβ1-42, and Aβ oligomers),119 matrix metalloproteinases 2, 3 and 9,120 glutamate carboxypeptidase II,121 endothelin-converting enzyme,122 tissue plasminogen activator,123 plasmin,120 angiotensin-converting enzyme,120 and insulin-degrading enzyme.",
      "key": "c148e8bcf96c6ffd202b8b1d399a57d9",
      "line": 261,
      "object": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        },
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 41,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Specifically, ISF Aβ can be taken up by microglia and astrocytes, whereas perivascular Aβ can be degraded by vascular smooth muscle cells, perivascular macrophages, and astrocytes",
      "key": "3b4f9f45af83b4873ced482b651465ad",
      "line": 268,
      "object": {
        "location": {
          "name": "Extracellular Fluid",
          "namespace": "MESH"
        }
      },
      "relation": "decreases",
      "source": 19,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Extracellular Space": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Third, plaques activate the immune effectors of the CNS—microglia and astrocytes129—inducing both phagocytosis of Aβ, which facilitates clearance from the extracellular space, and production of neurotoxic inflammatory cytokines.",
      "key": "7137af0496bddeb6ac0cdd533a6e944b",
      "line": 306,
      "relation": "decreases",
      "source": 19,
      "subject": {
        "modifier": "Activity"
      },
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Extracellular Space": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Third, plaques activate the immune effectors of the CNS—microglia and astrocytes129—inducing both phagocytosis of Aβ, which facilitates clearance from the extracellular space, and production of neurotoxic inflammatory cytokines.",
      "key": "fd32919e8acf7919e342200cfd1d5f1a",
      "line": 308,
      "relation": "increases",
      "source": 19,
      "subject": {
        "modifier": "Activity"
      },
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Specifically, ISF Aβ can be taken up by microglia and astrocytes, whereas perivascular Aβ can be degraded by vascular smooth muscle cells, perivascular macrophages, and astrocytes",
      "key": "3563fca4061619d1467d0da81d68ff3c",
      "line": 270,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 10,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " Specifically, ISF Aβ can be taken up by microglia and astrocytes, whereas perivascular Aβ can be degraded by vascular smooth muscle cells, perivascular macrophages, and astrocytes",
      "key": "5a9884996b12cf6ea7297c0ac5ac9b36",
      "line": 271,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 18,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Temporal Lobe": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "First, expression of neprilysin is decreased in AD,126 especially in regions with high Aβ loads such as the hippocampus and temporal gyrus.127 ",
      "key": "664cdf149f9f3e8d5b97a6b74a2ea813",
      "line": 279,
      "relation": "negativeCorrelation",
      "source": 76,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Second, both Aβ and insulin are ligands that compete for degradation by insulin-degrading enzyme; thus, hyper- insulinaemia can reduce clearance of Aβ, which might partly explain the link between type 2 diabetes mellitus and AD.",
      "key": "57a5cf0575556df1e5f40235586530c8",
      "line": 297,
      "relation": "increases",
      "source": 53,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Some evidence suggests that LRP1 is the main transporter for Aβ efflux at the BBB, whereas other studies have demonstrated its role to be quite minor.",
      "key": "340f15114a29d6d9d742b42d093706fe",
      "line": 316,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Brain",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Blood",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 54,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Specifically, local soluble Aβ is transferred from the interstitium to the brain by LDL receptor (LDLR) family members such as LRP1, and ATP-binding cassette transporters (ABC transporters).",
      "key": "a54359399c0c424069a7a7dfa0d45100",
      "line": 361,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Brain",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 54,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "ApoE is a cholesterol transporter that competes with Aβ for efflux by LRP1 from the interstitium into the circula- tion;",
      "key": "a563687bd37e76d29c5d79d004aeebe4",
      "line": 391,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cardiovascular System",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 54,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "In AD, these factors are impaired in a number of ways. First, expression of the blood efflux transporters LRP1 123 and ABCB1 147 is decreased, whereas expression of the blood influx transporter RAGE is upregulated.",
      "key": "c8b0fa2019fd0fc73a7358d932abeeee",
      "line": 375,
      "relation": "negativeCorrelation",
      "source": 54,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "ApoE is a cholesterol transporter that competes with Aβ for efflux by LRP1 from the interstitium into the circula- tion;",
      "key": "bf03696a93c7879106ba995e16fddc15",
      "line": 392,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cardiovascular System",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 54,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "The main ABC transporter responsible for Aβ efflux is ABCB1 (also known as P-glycoprotein 1 or MDR1),which directly exports Aβ into the circulation.",
      "key": "0f5a4d4e15f339e37103dcde15bdb9f7",
      "line": 322,
      "object": {
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 40,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "ABCA1, which is located on the abluminal side of the brain endo- thelium,140 does not directly bind and extrude Aβ,141 but mediates Aβ clearance in an ApoE-dependent manner.",
      "key": "23cf9a535f29c69d1acbccd24209f9f1",
      "line": 328,
      "object": {
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 40,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "The main ABC transporter responsible for Aβ efflux is ABCB1 (also known as P-glycoprotein 1 or MDR1), which directly exports Aβ into the circulation. ",
      "key": "16475511f304e223b2e2155f77cb24e1",
      "line": 368,
      "object": {
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 40,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "ABCA1, which is located on the abluminal side of the brain endo- thelium,140 does not directly bind and extrude Aβ,141 but mediates Aβ clearance in an ApoE-dependent manner.",
      "key": "1e1e594ec75e3f7e806b05be2f145b47",
      "line": 329,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 40,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "In AD, these factors are impaired in a number of ways. First, expression of the blood efflux transporters LRP1 123 and ABCB1 147 is decreased, whereas expression of the blood influx transporter RAGE is upregulated.",
      "key": "1735b13dbcd5a8b7b54610b6066e6ade",
      "line": 376,
      "relation": "negativeCorrelation",
      "source": 40,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "ABCA1, which is located on the abluminal side of the brain endo- thelium,140 does not directly bind and extrude Aβ,141 but mediates Aβ clearance in an ApoE-dependent manner.",
      "key": "9c3446a6cea2432401cf6fb56d46475a",
      "line": 330,
      "relation": "regulates",
      "source": 43,
      "subject": {
        "modifier": "Activity"
      },
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "ApoE is a cholesterol transporter that competes with Aβ for efflux by LRP1 from the interstitium into the circula- tion;",
      "key": "d161cd015b6ae06df8cbb55122b55108",
      "line": 393,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cardiovascular System",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "negativeCorrelation",
      "source": 43,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cardiovascular System",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "competition for shared receptors is the primary mechanism by which ApoE mediates Aβ clearance",
      "key": "483c974154cb74c832442e2d6e3509bb",
      "line": 399,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "regulates",
      "source": 43,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Blood-Brain Barrier": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Clearance of Aβ through the BBB is also medi- ated by α2-macroglobulin (α2M),14 and LDLR-related protein 2 (LRP2, also known as megalin) when LRP2 forms a complex with clusterin (also known as ApoJ).",
      "key": "7fa67065aea497882b58d4eb7889cd74",
      "line": 338,
      "relation": "decreases",
      "source": 39,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Blood-Brain Barrier": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Clearance of Aβ through the BBB is also medi- ated by α2-macroglobulin (α2M),14 and LDLR-related protein 2 (LRP2, also known as megalin) when LRP2 forms a complex with clusterin (also known as ApoJ).",
      "key": "60306fb5bbda86b4602468d8970515d5",
      "line": 339,
      "relation": "decreases",
      "source": 55,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Free Aβ can be transported from the circulation into the interstitium via RAGE (advanced glycosylation end product-specific receptor).",
      "key": "665d2c5fe6779925c63b9ec664b3d2fd",
      "line": 354,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Cardiovascular System",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 42,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "In AD, these factors are impaired in a number of ways. First, expression of the blood efflux transporters LRP1 123 and ABCB1 147 is decreased, whereas expression of the blood influx transporter RAGE is upregulated.",
      "key": "ed99b8739d7d527def02c8356d0d8e3e",
      "line": 377,
      "relation": "positiveCorrelation",
      "source": 42,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Specifically, local soluble Aβ is transferred from the interstitium to the brain by LDL receptor (LDLR) family members such as LRP1, and ATP-binding cassette transporters (ABC transporters).",
      "key": "05051d2ddfe62690b0cc892159240f8a",
      "line": 362,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Extracellular Space",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Brain",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 70,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Inflammation, a common feature of AD, can affect ligand affinity by making the pH more acidic, which promotes hyperphosphorylation of tau and induces conforma- tional changes in Aβ that hinder its clearance.",
      "key": "1dd59426135b1ed5de15d5bcda80858e",
      "line": 384,
      "relation": "increases",
      "source": 91,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Inflammation, a common feature of AD, can affect ligand affinity by making the pH more acidic, which promotes hyperphosphorylation of tau and induces conforma- tional changes in Aβ that hinder its clearance.",
      "key": "62a08cc517f4552f2f612716b93ac30f",
      "line": 385,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 91,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Third, ApoE4 is also associated with lower antioxidant activity than other ApoE isoforms,154,155 and it mediates BBB breakdown through a proinflammatory pathway involving cyclophilin A in pericytes.",
      "key": "df132600d17d8171bce5fca9b0177dc2",
      "line": 408,
      "relation": "decreases",
      "source": 67,
      "subject": {
        "modifier": "Activity"
      },
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "These findings are in line with evidence suggesting that increased oxi- dative stress157 and loss of vascular integrity contribute to ageing158 and AD,159 as demonstrated by accelerated breakdown of the BBB and the neurovascular unit.",
      "key": "fb8e61b7a19f071582b0d2eae47cbe97",
      "line": 415,
      "relation": "increases",
      "source": 24,
      "target": 87
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "These findings are in line with evidence suggesting that increased oxi- dative stress157 and loss of vascular integrity contribute to ageing158 and AD,159 as demonstrated by accelerated breakdown of the BBB and the neurovascular unit.",
      "key": "70d98008fe7079d002b5ceadb795744e",
      "line": 416,
      "relation": "increases",
      "source": 24,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "These findings are in line with evidence suggesting that increased oxi- dative stress157 and loss of vascular integrity contribute to ageing158 and AD,159 as demonstrated by accelerated breakdown of the BBB and the neurovascular unit.",
      "key": "4e37d8528d01605d6fabf805cfb9fdfa",
      "line": 417,
      "relation": "decreases",
      "source": 24,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Thus, sleep could indirectly increase BBB clearance of Aβ through increased glymphatic bulk flow, but it might also directly increase clearance through the BBB via various mechanisms, such as molecular changes (for example, upregulated LRP1), as seen with AD-protective physical and cognitive activity in mice.1",
      "key": "4df3675a7632c7d04857c705e857ba69",
      "line": 460,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 92,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Thus, sleep could indirectly increase BBB clearance of Aβ through increased glymphatic bulk flow, but it might also directly increase clearance through the BBB via various mechanisms, such as molecular changes (for example, upregulated LRP1), as seen with AD-protective physical and cognitive activity in mice.1",
      "key": "7ed4e8e87beca310ad34470d4d63b603",
      "line": 461,
      "relation": "decreases",
      "source": 92,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Thus, sleep could indirectly increase BBB clearance of Aβ through increased glymphatic bulk flow, but it might also directly increase clearance through the BBB via various mechanisms, such as molecular changes (for example, upregulated LRP1), as seen with AD-protective physical and cognitive activity in mice.1",
      "key": "2262c981964ce4b9838973c7ea8defd8",
      "line": 463,
      "relation": "increases",
      "source": 92,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " First, in ageing, and particularly in AD, CSF production by the choroid plexus is reduced, as shown by decreased water secretion into the ventricles via AQP1 water channels.",
      "key": "c7d12519db2421dc1da438682f84ab69",
      "line": 475,
      "relation": "negativeCorrelation",
      "source": 9,
      "target": 87
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " First, in ageing, and particularly in AD, CSF production by the choroid plexus is reduced, as shown by decreased water secretion into the ventricles via AQP1 water channels.",
      "key": "16ad82fa073ccc40c03809ad0a679111",
      "line": 476,
      "relation": "negativeCorrelation",
      "source": 9,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " First, in ageing, and particularly in AD, CSF production by the choroid plexus is reduced, as shown by decreased water secretion into the ventricles via AQP1 water channels.",
      "key": "ef2fd52a66df4a8a3b893802e2a89574",
      "line": 477,
      "relation": "negativeCorrelation",
      "source": 45,
      "subject": {
        "modifier": "Activity"
      },
      "target": 87
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " First, in ageing, and particularly in AD, CSF production by the choroid plexus is reduced, as shown by decreased water secretion into the ventricles via AQP1 water channels.",
      "key": "bf0a4aba741ff1bd93233d02c3445507",
      "line": 478,
      "relation": "negativeCorrelation",
      "source": 45,
      "subject": {
        "modifier": "Activity"
      },
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " First, in ageing, and particularly in AD, CSF production by the choroid plexus is reduced, as shown by decreased water secretion into the ventricles via AQP1 water channels.",
      "key": "f82239fedcf3c17378406bbcc7fc6644",
      "line": 479,
      "relation": "increases",
      "source": 45,
      "subject": {
        "modifier": "Activity"
      },
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": " First, in ageing, and particularly in AD, CSF production by the choroid plexus is reduced, as shown by decreased water secretion into the ventricles via AQP1 water channels.",
      "key": "b0a9b936bc3163ee1c7182f97a3e1f79",
      "line": 480,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 45,
      "subject": {
        "modifier": "Activity"
      },
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Choroid Plexus": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "In AD, the choroid plexus undergoes many structural changes, such as calcification, fibrosis and Aβ deposition, all of which can obstruct CSF production.",
      "key": "6fcc23f792bee819693e22d96269b930",
      "line": 490,
      "relation": "decreases",
      "source": 79,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Choroid Plexus": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "In AD, the choroid plexus undergoes many structural changes, such as calcification, fibrosis and Aβ deposition, all of which can obstruct CSF production.",
      "key": "28e56297d5d05a6ad398241a084cd79f",
      "line": 491,
      "relation": "decreases",
      "source": 89,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Tau is mainly cleared through intracellular degrada- tion by lysosomes via the autophagy–lysosome pathway, and by proteasomes via the ubiquitin–proteasome pathway.202 ",
      "key": "4abc17fcd4adbf6df91f5159c70e7268",
      "line": 501,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 75,
      "subject": {
        "modifier": "Activity"
      },
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Phosphorylation of tau by protein kinase A increases its resistance to degradation by calpain",
      "key": "b015efda9d58152b780feb22d2cfdca1",
      "line": 508,
      "relation": "increases",
      "source": 37,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Phosphorylation of tau by protein kinase A increases its resistance to degradation by calpain",
      "key": "5f970e3a64f55561c000673196cc787d",
      "line": 509,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 58,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "Phosphorylation of tau by protein kinase A increases its resistance to degradation by calpain",
      "key": "0ad494e9630a2c8435200f523c0a61cf",
      "line": 510,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 72,
      "subject": {
        "modifier": "Activity"
      },
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "These findings support the link between TBI and tau aggre- gation, with resulting neurodegeneration similar to that seen in AD and chronic traumatic encephalopathy",
      "key": "378a30d3f917a8190e52bb62615f3c9c",
      "line": 517,
      "relation": "association",
      "source": 78,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "These findings support the link between TBI and tau aggre- gation, with resulting neurodegeneration similar to that seen in AD and chronic traumatic encephalopathy",
      "key": "65332f3224afdfc63005c94bf06bce19",
      "line": 517,
      "relation": "association",
      "source": 35,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "MeSHDisease": {
          "Brain Injuries, Traumatic": true
        }
      },
      "citation": {
        "authors": [
          "Axel L",
          "Blennow K",
          "Butler T",
          "Carare RO",
          "Fieremans E",
          "Frangione B",
          "Glodzik L",
          "Ménard J",
          "Nicholson C",
          "Osorio RS",
          "Rusinek H",
          "Tarasoff-Conway JM",
          "Wisniewski T",
          "Zetterberg H",
          "Zlokovic BV",
          "de Leon MJ"
        ],
        "date": "2015-08-01",
        "db": "PubMed",
        "db_id": "26195256",
        "db_name": "Clearance systems in the brain-implications for Alzheimer disease.",
        "first": "Tarasoff-Conway JM",
        "journal": "Nature reviews. Neurology",
        "last": "de Leon MJ",
        "pages": "457-70",
        "volume": "11"
      },
      "evidence": "These findings support the link between TBI and tau aggre- gation, with resulting neurodegeneration similar to that seen in AD and chronic traumatic encephalopathy",
      "key": "c8de03f2005f3feb5641ecd90e79f1d4",
      "line": 519,
      "relation": "increases",
      "source": 35,
      "target": 84
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 40\")",
      "concept": {
        "name": "amyloid-beta polypeptide 40",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "9e0dfb730cc36c0afbaa05a340211fda"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 42\")",
      "concept": {
        "name": "amyloid-beta polypeptide 42",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "ef705fbb8d4e7ba18fb04daf5d329b6b"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "concept": {
        "name": "amyloid-beta",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e9557ea6ec74113b73fe23f4bd76b524"
    },
    {
      "bel": "a(CHEBI:water)",
      "concept": {
        "name": "water",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e31ca77d03bf761df47ae2a13a76e794"
    },
    {
      "bel": "a(CONSO:\"amyloid-beta aggregates\")",
      "concept": {
        "name": "amyloid-beta aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "cb9ddfdb593aa8073305b79828d71376"
    },
    {
      "bel": "a(CONSO:\"amyloid-beta derived diffusible ligands\")",
      "concept": {
        "name": "amyloid-beta derived diffusible ligands",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "b198bfd04e50cfcecc9ea9c71403ef51"
    },
    {
      "bel": "a(MESH:\"Blood-Brain Barrier\")",
      "concept": {
        "name": "Blood-Brain Barrier",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "63dcf0f7f45e2c3862eb5a77da5f2627"
    },
    {
      "bel": "a(MESH:\"Cerebral Cortex\")",
      "concept": {
        "name": "Cerebral Cortex",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "077de1b5bd239fcc1b5ed7bec5aa46cf"
    },
    {
      "bel": "a(MESH:\"Cerebral Ventricles\")",
      "concept": {
        "name": "Cerebral Ventricles",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "a85832a5fd1f8535071bd05fc9b8e8c9"
    },
    {
      "bel": "a(MESH:\"Cerebrospinal Fluid\")",
      "concept": {
        "name": "Cerebrospinal Fluid",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "4263297d8284632a8fd9bed2470cb4a0"
    },
    {
      "bel": "a(MESH:\"Muscle, Smooth, Vascular\")",
      "concept": {
        "name": "Muscle, Smooth, Vascular",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "6c5656094da94763532511ed2cc7cd87"
    },
    {
      "bel": "a(MESH:\"Neurofibrillary Tangles\")",
      "concept": {
        "name": "Neurofibrillary Tangles",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "1ea09b7aace0ed3a0da3f815bd92b304"
    },
    {
      "bel": "a(MESH:\"Neuropil Threads\")",
      "concept": {
        "name": "Neuropil Threads",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "7a2395c6551685ba58951a397eaabc82"
    },
    {
      "bel": "a(MESH:\"White Matter\")",
      "concept": {
        "name": "White Matter",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "6e71bab67d66a2370343d976a22bf3b0"
    },
    {
      "bel": "a(MESH:Astrocytes)",
      "concept": {
        "name": "Astrocytes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f02fc0f5c8a1ab66a9a7d9130d56d6fe"
    },
    {
      "bel": "a(MESH:Cytokines)",
      "concept": {
        "name": "Cytokines",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "0d3c01297f25a34285f54b350178a231"
    },
    {
      "bel": "a(MESH:Endosomes)",
      "concept": {
        "name": "Endosomes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "611555802609a5ba1dd2a7d2e1c083ff"
    },
    {
      "bel": "a(MESH:Lysosomes)",
      "concept": {
        "name": "Lysosomes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "1300f9eaf6ae0aca114e8d609f9a365d"
    },
    {
      "bel": "a(MESH:Macrophages)",
      "concept": {
        "name": "Macrophages",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "311e39dad42597c983d7962f84ee92b6"
    },
    {
      "bel": "a(MESH:Microglia)",
      "concept": {
        "name": "Microglia",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "4ef490b325b2b1e33e41b4e22e1bd8c6"
    },
    {
      "bel": "bp(GO:\"establishment of blood-brain barrier\")",
      "concept": {
        "name": "establishment of blood-brain barrier",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c3014893df4d7debb8c78dc9ea16046b"
    },
    {
      "bel": "bp(GO:\"glucose metabolic process\")",
      "concept": {
        "name": "glucose metabolic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "57837c8bd480cd6e4257602591b12dac"
    },
    {
      "bel": "bp(GO:\"protein catabolic process\")",
      "concept": {
        "name": "protein catabolic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "b670adb6c51d1078c8508e861db111a1"
    },
    {
      "bel": "bp(GO:autophagy)",
      "concept": {
        "name": "autophagy",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "9efc965fac6a195d0fad26eecddaac05"
    },
    {
      "bel": "bp(MESH:\"Oxidative Stress\")",
      "concept": {
        "name": "Oxidative Stress",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "9174b724412892a12c4da7cab55f893c"
    },
    {
      "bel": "bp(MESH:Exercise)",
      "concept": {
        "name": "Exercise",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "19d616a3efc548d4e89da34be55fc414"
    },
    {
      "bel": "complex(a(MESH:Endosomes), a(MESH:Lysosomes))",
      "function": "Complex",
      "id": "cc8a8e28b6f66406ecb2b83a91bf1f22",
      "members": [
        {
          "bel": "a(MESH:Endosomes)",
          "concept": {
            "name": "Endosomes",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "611555802609a5ba1dd2a7d2e1c083ff"
        },
        {
          "bel": "a(MESH:Lysosomes)",
          "concept": {
            "name": "Lysosomes",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "1300f9eaf6ae0aca114e8d609f9a365d"
        }
      ]
    },
    {
      "bel": "g(CONSO:\"APOE e4\")",
      "concept": {
        "name": "APOE e4",
        "namespace": "CONSO"
      },
      "function": "Gene",
      "id": "a2483d5c80d7b5b3f6695d158215b84b"
    },
    {
      "bel": "g(HGNC:APP)",
      "concept": {
        "name": "APP",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "07bfb6a4d8848e0b6508b5117276aa8c"
    },
    {
      "bel": "g(HGNC:APP, var(\"?\"))",
      "concept": {
        "name": "APP",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "0492aeca62dd861fba5c71f4e754d8df",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "g(HGNC:PSEN1)",
      "concept": {
        "name": "PSEN1",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "ac3ba1216f5c63a9d3ce7d9dbac01097"
    },
    {
      "bel": "g(HGNC:PSEN1, var(\"?\"))",
      "concept": {
        "name": "PSEN1",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "2ba03d302ba26dc7123ca9a60791d313",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "g(HGNC:PSEN2)",
      "concept": {
        "name": "PSEN2",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "ce4833998ad061514c37c9b5881bd549"
    },
    {
      "bel": "g(HGNC:PSEN2, var(\"?\"))",
      "concept": {
        "name": "PSEN2",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "63e6f5412d6c2d9c2a434c0d1e24295a",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"APP C-terminally truncated carboxyl-terminal fragments\")",
      "concept": {
        "name": "APP C-terminally truncated carboxyl-terminal fragments",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "e74c619edc3731c06f4ce8315ab08668"
    },
    {
      "bel": "p(CONSO:\"Tau aggregates\")",
      "concept": {
        "name": "Tau aggregates",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "d03adc6b1e424e742ba646d63a61f48e"
    },
    {
      "bel": "p(FPLX:\"Gamma_secretase\")",
      "concept": {
        "name": "Gamma_secretase",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "e5aa42b4d5a7992fe30ecc5d01ae8dd8"
    },
    {
      "bel": "p(FPLX:PKA)",
      "concept": {
        "name": "PKA",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "7f28e2fd1e77e23e3fafb2c1c0969bc3"
    },
    {
      "bel": "p(FPLX:Proteasome)",
      "concept": {
        "name": "Proteasome",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "f9a5ccb3d3118a604efa68f854b03149"
    },
    {
      "bel": "p(HGNC:A2M)",
      "concept": {
        "name": "A2M",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b8f2208624b268637a622373a3bffd99"
    },
    {
      "bel": "p(HGNC:ABCB1)",
      "concept": {
        "name": "ABCB1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "9589d1bee328c32597838df3a63cf067"
    },
    {
      "bel": "p(HGNC:ACE)",
      "concept": {
        "name": "ACE",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a42fa7a0be4ac760f67482e649ad0441"
    },
    {
      "bel": "p(HGNC:AGER)",
      "concept": {
        "name": "AGER",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6438987a3f1a4ac86a4360bddbf0bc6a"
    },
    {
      "bel": "p(HGNC:APOE)",
      "concept": {
        "name": "APOE",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6400bf22ba3f98800eca81c8702b5e39"
    },
    {
      "bel": "p(HGNC:APP)",
      "concept": {
        "name": "APP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d43ae551265c6b6a27038d0b036848cf"
    },
    {
      "bel": "p(HGNC:AQP1)",
      "concept": {
        "name": "AQP1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ecb1afcebf9d7740deba9adb6ce392d9"
    },
    {
      "bel": "p(HGNC:BACE1)",
      "concept": {
        "name": "BACE1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "334dd03e9a5f223f13995e497b1c156e"
    },
    {
      "bel": "p(HGNC:CLU)",
      "concept": {
        "name": "CLU",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c2a79190d5cc66aca38b295b7bd87118"
    },
    {
      "bel": "p(HGNC:CLU, var(\"?\"))",
      "concept": {
        "name": "CLU",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "41e67f29c9d10b32a0705a6fb00ea378",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:ECE1)",
      "concept": {
        "name": "ECE1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ed34302995af0526bb1e3e46e42f0ea6"
    },
    {
      "bel": "p(HGNC:ECE2)",
      "concept": {
        "name": "ECE2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "22b053c2fe63c8d51de1eee6668df3fb"
    },
    {
      "bel": "p(HGNC:FOLH1)",
      "concept": {
        "name": "FOLH1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "493da355d83a1e00d0220ba8fb8341f1"
    },
    {
      "bel": "p(HGNC:IDE)",
      "concept": {
        "name": "IDE",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "1b1adb12a1eb23245eaa21ff477ee4c5"
    },
    {
      "bel": "p(HGNC:INS)",
      "concept": {
        "name": "INS",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8881d4b8b4ccc786ec16e65d812dd184"
    },
    {
      "bel": "p(HGNC:LRP1)",
      "concept": {
        "name": "LRP1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "068524d49458533342e2e490606d63eb"
    },
    {
      "bel": "p(HGNC:LRP2)",
      "concept": {
        "name": "LRP2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7be584f17a86492a16b0ef7288519c04"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d1009217050e75d549c8c5aa83309a8"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(CONSO:hyperphosphorylation))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0d2d8072f03dcdf148e658067d37b9cb",
      "variants": [
        {
          "concept": {
            "name": "hyperphosphorylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a8fb3a87d5a0672c07462bb17c8b0947",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MME)",
      "concept": {
        "name": "MME",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "04750748cf48f0571332caef677ccd34"
    },
    {
      "bel": "p(HGNC:MMP2)",
      "concept": {
        "name": "MMP2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "78511410fc96842c39ecd264fc2ea9e0"
    },
    {
      "bel": "p(HGNC:MMP3)",
      "concept": {
        "name": "MMP3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e3408dd2587dc1d684573dd9d31a489e"
    },
    {
      "bel": "p(HGNC:MMP9)",
      "concept": {
        "name": "MMP9",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d2dacdba7b2b8a703a224d03f2f2fb98"
    },
    {
      "bel": "p(HGNC:PICALM)",
      "concept": {
        "name": "PICALM",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "03d6811a2574eba4e6224119733b3385"
    },
    {
      "bel": "p(HGNC:PICALM, var(\"?\"))",
      "concept": {
        "name": "PICALM",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "09f51fe1048fa56c90b626ace4c9902d",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:PLAT)",
      "concept": {
        "name": "PLAT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a551714fbe85c0e3317a94b281d20c69"
    },
    {
      "bel": "p(HGNC:PLG)",
      "concept": {
        "name": "PLG",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f26ffa1f3ffe1139d4072df0b0797f10"
    },
    {
      "bel": "p(HGNC:PPIA)",
      "concept": {
        "name": "PPIA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "9f94505055c238d28e7945e0ce43fabf"
    },
    {
      "bel": "p(HGNC:TREM2)",
      "concept": {
        "name": "TREM2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c3044030c371598598bb85b0321d03ea"
    },
    {
      "bel": "p(HGNC:TREM2, var(\"?\"))",
      "concept": {
        "name": "TREM2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "2ca3f90aadd35ed783db3fede5bf0904",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(MESH:\"ATP-Binding Cassette Transporters\")",
      "concept": {
        "name": "ATP-Binding Cassette Transporters",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "4200123f525be8eae4725e51fd3d9d04"
    },
    {
      "bel": "p(MESH:\"Amyloid Precursor Protein Secretases\")",
      "concept": {
        "name": "Amyloid Precursor Protein Secretases",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "9fd73a5cf2d0a2bc2ef5d992e16c496e"
    },
    {
      "bel": "p(MESH:Calpain)",
      "concept": {
        "name": "Calpain",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "ed4f14ec128dc45efe320bece3ec8dd1"
    },
    {
      "bel": "p(MESH:Cathepsins)",
      "concept": {
        "name": "Cathepsins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "dfcba66dc985d7af0d2ac6fe4f282757"
    },
    {
      "bel": "p(MESH:Endopeptidases)",
      "concept": {
        "name": "Endopeptidases",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "b8dee6f2bcaaf24354a6ad9ac6717d71"
    },
    {
      "bel": "p(MESH:Lysosomes)",
      "concept": {
        "name": "Lysosomes",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "de703e9ac7fc292566ddd33e693a331e"
    },
    {
      "bel": "p(MESH:Neprilysin)",
      "concept": {
        "name": "Neprilysin",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "47f4876754ebbecb5e8205012db9a930"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "concept": {
        "name": "Alzheimer Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2ae8307f5fd59056199369691367cc96"
    },
    {
      "bel": "path(MESH:\"Brain Injuries, Traumatic\")",
      "concept": {
        "name": "Brain Injuries, Traumatic",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "3c4b2cad0bdee5fabf9b605909a70f3b"
    },
    {
      "bel": "path(MESH:\"Calcification, Physiologic\")",
      "concept": {
        "name": "Calcification, Physiologic",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "92d268507fc6865715e02d6d263ed1c3"
    },
    {
      "bel": "path(MESH:\"Cardiovascular Diseases\")",
      "concept": {
        "name": "Cardiovascular Diseases",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "b23198e180b52cff18e09a730c87b095"
    },
    {
      "bel": "path(MESH:\"Cerebral Amyloid Angiopathy\")",
      "concept": {
        "name": "Cerebral Amyloid Angiopathy",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "5e1d9ab98aa7fa9abd77b3d1f8185a3e"
    },
    {
      "bel": "path(MESH:\"Craniocerebral Trauma\")",
      "concept": {
        "name": "Craniocerebral Trauma",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "a86e4e262d2f1269794e83f356e84b28"
    },
    {
      "bel": "path(MESH:\"Diabetes Mellitus\")",
      "concept": {
        "name": "Diabetes Mellitus",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2536452fb299e85b5e69c7e8a161df01"
    },
    {
      "bel": "path(MESH:\"Neurodegenerative Diseases\")",
      "concept": {
        "name": "Neurodegenerative Diseases",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "c04acd23e7e69b92e4e4230d8551fcf4"
    },
    {
      "bel": "path(MESH:\"Plaque, Amyloid\")",
      "concept": {
        "name": "Plaque, Amyloid",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "ff45c3caeb411cd232d96d6ed01854d5"
    },
    {
      "bel": "path(MESH:\"Sleep Initiation and Maintenance Disorders\")",
      "concept": {
        "name": "Sleep Initiation and Maintenance Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "0269863fa44919f0f8024eacef024579"
    },
    {
      "bel": "path(MESH:Aging)",
      "concept": {
        "name": "Aging",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "b6a3eeccec3150857599adf152d20e7c"
    },
    {
      "bel": "path(MESH:Atrophy)",
      "concept": {
        "name": "Atrophy",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "7d5394b2784c6e661c25500d859dc266"
    },
    {
      "bel": "path(MESH:Fibrosis)",
      "concept": {
        "name": "Fibrosis",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "dcbee08c082ce3d1f58a75056c14c66f"
    },
    {
      "bel": "path(MESH:Hypertension)",
      "concept": {
        "name": "Hypertension",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "dfc5303e42570a3507bbb51f1a445664"
    },
    {
      "bel": "path(MESH:Inflammation)",
      "concept": {
        "name": "Inflammation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "10cd96fd4056a5e6c27264e0130e89f9"
    },
    {
      "bel": "path(MESH:Sleep)",
      "concept": {
        "name": "Sleep",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "93e909729bcb90aaf68722849eb4300c"
    },
    {
      "bel": "path(MESH:Thinking)",
      "concept": {
        "name": "Thinking",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "10f575a8f8da54faa357010445879ac3"
    },
    {
      "bel": "rxn(reactants(p(HGNC:APP)), products(a(CHEBI:\"amyloid-beta\"), p(CONSO:\"APP C-terminally truncated carboxyl-terminal fragments\")))",
      "function": "Reaction",
      "id": "6c31d8eb7296f485dc0006ae68ce96ca",
      "products": [
        {
          "bel": "a(CHEBI:\"amyloid-beta\")",
          "concept": {
            "name": "amyloid-beta",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "e9557ea6ec74113b73fe23f4bd76b524"
        },
        {
          "bel": "p(CONSO:\"APP C-terminally truncated carboxyl-terminal fragments\")",
          "concept": {
            "name": "APP C-terminally truncated carboxyl-terminal fragments",
            "namespace": "CONSO"
          },
          "function": "Protein",
          "id": "e74c619edc3731c06f4ce8315ab08668"
        }
      ],
      "reactants": [
        {
          "bel": "p(HGNC:APP)",
          "concept": {
            "name": "APP",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "d43ae551265c6b6a27038d0b036848cf"
        }
      ]
    }
  ]
}